成大醫院心臟內科、腫瘤醫學部與乳房外科三大團隊,完成全球首項以新一代心衰竭藥物「血管張力素受體-腦啡肽酶抑制劑」(Angiotensin Receptor-Neprilysin Inhibitor, ARNI)預防癌症治療誘發心臟毒性(Cancer Therapy-Related C...
2025-07-14 12:21
2025-07-09 10:30
2025-07-04 13:52
2025-07-01 12:48
2025-06-30 13:06
2025-06-26 10:48
2025-06-24 13:44
2025-06-20 21:30
2025-06-09 15:10